✦ LIBER ✦

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

✍ Scribed by László Herszényi; Fabio Farinati; Romilda Cardin; Gábor István; László D Molnár; István Hritz; Massimo De Paoli; Mario Plebani; Zsolt Tulassay

Book ID: 115011297
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 390 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cathepsin-D, urokinase plasminogen activ

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

✍ Jahkola, T; Toivonen, T; Smitten, K von; Virtanen, I; Wasenius, V-M; Blomqvist, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

Clinical Relevance of Urokinase-Type Pla

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

✍ Coşkun Tecimer; David L. Doering; L.Jane Goldsmith; John S. Meyer; Gazi Abdulhay 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Expression of matrix metalloproteinases-

Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma

✍ Takahiko Naka; Doerthe Kuester; Carsten Boltze; Torss-Oliver Schulz; Amir Samii; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 945 KB

Prognostic value of urokinase-type plasm

Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer

✍ Schmitt, M.; Jänicke, F.; Thomssen, C.; Pache, L.; Bläser, J.; Oppelt, P.; Tsche 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Pooled Analysis of Prognostic Impact of

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

✍ Look, M. P.; van Putten, W. L. J.; Duffy, M. J.; Harbeck, N.; Christensen, I. J. 📂 Article 📅 2002 🏛 Oxford University Press 🌐 English ⚖ 360 KB

Expression of Urokinase-Type Plasminogen

Expression of Urokinase-Type Plasminogen Activator (uPA), its Receptor (uPAR), and Inhibitor (PAI-1) in Human Breast Carcinomas and Their Clinical Relevance

✍ Sarah A. Andres; Angelena B. Edwards; James L. Wittliff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB